XNCR
Xencor Inc
Nasdaq Pharmaceutical Preparations Accelerated filer

Key Financials

Total Liabilities
$239.9M
↓ 13.7%
Revenue
$125.6M
↑ 13.7%
Shareholders' Equity
$635.6M
↓ 6.2%
Net Income
$-91923000
↑ 60.5%
Operating Income
$-177502000
↑ 0.5%
Total Assets
$875.5M
↓ 8.0%
Cash & Equivalents
$54.1M
↑ 32.3%
EPS (Diluted)
$-1.24
↑ 65.4%

Recent SEC Filings

Form Type Filed Date Link
4 6/17/2026 View on SEC
4 6/17/2026 View on SEC
4 6/17/2026 View on SEC
4 6/17/2026 View on SEC
144 6/15/2026 View on SEC
144 6/15/2026 View on SEC
144 6/15/2026 View on SEC
144 6/15/2026 View on SEC
SCHEDULE 13G/A 5/15/2026 View on SEC
10-Q 5/6/2026 View on SEC

Company Information

Field Value
Ticker XNCR
Company Name Xencor Inc
CIK 1326732
Sector Pharmaceutical Preparations
Industry Accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 626-305-5900